These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
26. Immunology of Crohn's disease. Braat H; Peppelenbosch MP; Hommes DW Ann N Y Acad Sci; 2006 Aug; 1072():135-54. PubMed ID: 17057196 [TBL] [Abstract][Full Text] [Related]
27. Impaired dendritic cell function in Crohn's disease patients with NOD2 3020insC mutation. Kramer M; Netea MG; de Jong DJ; Kullberg BJ; Adema GJ J Leukoc Biol; 2006 Apr; 79(4):860-6. PubMed ID: 16461743 [TBL] [Abstract][Full Text] [Related]
28. Host-microbe interaction: mechanisms of defensin deficiency in Crohn's disease. Wang G; Stange EF; Wehkamp J Expert Rev Anti Infect Ther; 2007 Dec; 5(6):1049-57. PubMed ID: 18039087 [TBL] [Abstract][Full Text] [Related]
29. [Natural immunologic function of Paneth cells in small intestine of patients with Crohn's disease]. Maemoto A Hokkaido Igaku Zasshi; 2004 Mar; 79(2):129-36. PubMed ID: 15101188 [No Abstract] [Full Text] [Related]
30. Crohn's disease is associated with polymorphism of CARD15/NOD2 gene in a Hungarian population. Nagy Z; Karádi O; Rumi G; Rumi G; Pár A; Mózsik G; Czirják L; Süto G Ann N Y Acad Sci; 2005 Jun; 1051():45-51. PubMed ID: 16126943 [TBL] [Abstract][Full Text] [Related]
31. Increased intestinal permeability and NOD2 variants in familial and sporadic Crohn's disease. D'Incà R; Annese V; di Leo V; Latiano A; Quaino V; Abazia C; Vettorato MG; Sturniolo GC Aliment Pharmacol Ther; 2006 May; 23(10):1455-61. PubMed ID: 16669960 [TBL] [Abstract][Full Text] [Related]
32. Defensins and inflammation: the role of defensins in inflammatory bowel disease. Ramasundara M; Leach ST; Lemberg DA; Day AS J Gastroenterol Hepatol; 2009 Feb; 24(2):202-8. PubMed ID: 19215333 [TBL] [Abstract][Full Text] [Related]
33. Stem cell transplantation for Crohn's disease. Hawkey CJ Best Pract Res Clin Haematol; 2004 Jun; 17(2):317-25. PubMed ID: 15302343 [TBL] [Abstract][Full Text] [Related]
34. NOD2 and Crohn's disease: loss or gain of function? Eckmann L; Karin M Immunity; 2005 Jun; 22(6):661-7. PubMed ID: 15963781 [TBL] [Abstract][Full Text] [Related]
35. Mapping the effects of genetic susceptibility and Mycobacterium avium subsp. paratuberculosis infection on Crohn's disease: strong but independent. Sieswerda LE; Bannatyne RM J Clin Microbiol; 2006 Mar; 44(3):1204-5. PubMed ID: 16517933 [No Abstract] [Full Text] [Related]
36. Defensin deficiency, intestinal microbes, and the clinical phenotypes of Crohn's disease. Wehkamp J; Schmid M; Fellermann K; Stange EF J Leukoc Biol; 2005 Apr; 77(4):460-5. PubMed ID: 15618294 [TBL] [Abstract][Full Text] [Related]
37. Nod2-dependent regulation of innate and adaptive immunity in the intestinal tract. Kobayashi KS; Chamaillard M; Ogura Y; Henegariu O; Inohara N; Nuñez G; Flavell RA Science; 2005 Feb; 307(5710):731-4. PubMed ID: 15692051 [TBL] [Abstract][Full Text] [Related]
38. CARD15 allele frequency differences in New Zealand Maori: ancestry specific susceptibility to Crohn's disease in New Zealand? Gearry RB; Lea RA; Roberts RL; Chambers GK; Barclay ML; Kennedy MA Gut; 2006 Apr; 55(4):580. PubMed ID: 16531539 [No Abstract] [Full Text] [Related]
39. Paneth cells and the innate immune response. Wehkamp J; Stange EF Curr Opin Gastroenterol; 2006 Nov; 22(6):644-50. PubMed ID: 17053443 [TBL] [Abstract][Full Text] [Related]
40. Getting to the guts of NOD2. Kelsall B Nat Med; 2005 Apr; 11(4):383-4. PubMed ID: 15812518 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]